This page shows the latest pricing model news and features for those working in and with pharma, biotech and healthcare.
EQRx is co-founded by Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center whose academic interests focus on pricing as well as ... Bach recently proposed a model for selecting drugs for pricing
a cap on Medicare out of pocket payments, and supported value-based payments as a future pricing model. ... grilling. Despite being a longstanding critic of pharma’s pricing, Grassley has also indicated he wants to work with the sector on reform if
The Repatha discount comes as the US administration is ramping up the pressure on the biopharma industry on drug pricing, most recently proposing a reference pricing model to bring process closer
Gellad also says in a blog post on Stat News that the plans are long on rhetoric but short on concrete plans to implement the reference pricing system, providing “just a
Cost: agree a clear pricing model, which could be licence- or transaction-based and may also have elements of risk and reward.
evidence route which would demonstrate the benefits of the treatment and allow an outcomes-based pricing model.
More from news
Approximately 0 fully matching, plus 23 partially matching documents found.
The challenge of adapting pricing models to accommodate new therapies. By Walter Colasante. ... pricing model.
that we need to return to servicing a high-volume, low-cost model in consumer healthcare, and a parity pricing model in Rx.
to pursue a “robust” pricing model. ... Pharmaceuticals. He has also written a letter to employees to assuage their concerns over company's business model, potential exposure and the fall in the company's stock price (it fell
These are good examples of where legislation helps promote innovation, but unfortunately it's the access to markets, pricing and reimbursement that are deteriorating. ... I have worked very closely with the Swedish government to shape value-based-pricing.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
concerns. New entrants at both ends of the pricing spectrum. So while challenges remain, biosimilars seem to be finding their place in the market and creating a new and interesting dynamic, ... the system with a manageable pricing model to suit.
Following the publication of the new edition of The Price of Global Health, Ed Schoonveld writes about the industry's need for new drug pricing model. ... Does the drug industry need a new pricing model? Read Ed Schoonveld's article here . The new
Determine your pricing model: overcome governmental challenges and hear about what worked for Roche in Vietnam. ... Safeguard your reputation:employ a model of good corporate governance and learn how to overcome local corruptio n.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...